Projects
(Principal Investigator)



Results 1-15 of 15 (Search time: 0.003 seconds).

Start DateTitleP-InvestigatorFunding Organization/經費來源
2021)為標的之抑制策略以提高”阻斷PD-1之癌症免疫治療”的療效CHIH-HUNG HSUMinistry of Science and Technology
2020)為標的之抑制策略以提高”阻斷PD-1之癌症免疫治療”的療效CHIH-HUNG HSUMinistry of Science and Technology
2019)為標的之抑制策略以提高”阻斷PD-1之癌症免疫治療”的療效CHIH-HUNG HSUMinistry of Science and Technology
2013(100cap020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (III)CHIH-HUNG HSUMinistry of Science and Technology
2012(100CAP020-2) In vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (II)CHIH-HUNG HSUMinistry of Science and Technology
2011(100CAP020-2) in vivo Resistant Mechanisms of Sorafenib in Hepatocellular Carcinoma (HCC)---Development of Predictive Biomarkers and Resistance-Reversing Strategies (I)CHIH-HUNG HSUMinistry of Science and Technology
2010Exploring Molecular Targets for the Treatment of Hepatocellular Carcinoma---An Alternative ApproachCHIH-HUNG HSUMinistry of Science and Technology
2010Factors Affecting Biomarker Detection for the Implementation of Personalized Therapy for Hepatocellular Carcinoma (HCC) and Their Optimization (II)CHIH-HUNG HSUMinistry of Science and Technology
2009Exploring Molecular Targets for the Treatment of Hepatocellular Carcinoma---An Alternative ApproachCHIH-HUNG HSUMinistry of Science and Technology
2008Exploring Molecular Targets for the Treatment of Hepatocellular Carcinoma---An Alternative ApproachCHIH-HUNG HSUMinistry of Science and Technology
2007PI3K/Akt/mTOR Pathway-Targeting Agents in the Treatment of Hepatocellular Carcinoma---Exploration of the Possible Clinical Applications and the Molecular MechanismsCHIH-HUNG HSUMinistry of Science and Technology
2006PI3K/Akt/mTOR Pathway-Targeting Agents in the Treatment of Hepatocellular Carcinoma---Exploration of the Possible Clinical Applications and the Molecular MechanismsCHIH-HUNG HSUMinistry of Science and Technology
2005Targeting PI3K/AKT and Related Signaling Pathways in the Treatment of Nasopharyngeal Carcinoma---Further Exploration of the Molecular Mechanisms and Clinical ImplicationsCHIH-HUNG HSUMinistry of Science and Technology
2002Studies on the Mechanisms of Activation of Hepatitis B Virus (HBV) Replication Induced by Anticancer DrugsCHIH-HUNG HSUMinistry of Science and Technology
2001Studies on Epstein-Barr Virus (EBV) Reactivation Induced by Anti-Cancer Drugs---Mechanisms and Clinical SignificanceCHIH-HUNG HSUMinistry of Science and Technology